tomatidine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, I; Algahtani, FD; Aouadi, K; Iriti, M; Kadri, A; Noumi, E; Patel, H; Saeed, M; Snoussi, M; Sulaiman, S; Tasleem, M; Zrieq, R | 1 |
1 other study(ies) available for tomatidine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; COVID-19; COVID-19 Drug Treatment; Endoribonucleases; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2; Sesquiterpenes; Tomatine; Viral Nonstructural Proteins | 2021 |